Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In
  • Log Out

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
  • Log Out
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Peripheral Blood Perfusion Correlates with Microvascular Abnormalities in Systemic Sclerosis: A Laser-Doppler and Nailfold Videocapillaroscopy Study

MAURIZIO CUTOLO, CARMELA FERRONE, CARMEN PIZZORNI, STEFANO SOLDANO, BRUNO SERIOLO and ALBERTO SULLI
The Journal of Rheumatology June 2010, 37 (6) 1174-1180; DOI: https://doi.org/10.3899/jrheum.091356
MAURIZIO CUTOLO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mcutolo@unige.it
CARMELA FERRONE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CARMEN PIZZORNI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEFANO SOLDANO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BRUNO SERIOLO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALBERTO SULLI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Abstract

Objective. To investigate possible correlations between fingertip blood perfusion (FBP) status, assessed by laser Doppler flowmetry (LDF), and morphological microvascular abnormalities, detected by nailfold videocapillaroscopy (NVC), in patients with systemic sclerosis (SSc). The effects on FBP of intravenous (IV) treatment with the prostacyclin analog iloprost were also investigated.

Methods. Thirty-four consecutive patients with SSc and 16 healthy subjects were evaluated. LDF was performed by analyzing blood perfusion at the fingertips in both hands. Patients with SSc were distributed into the appropriate NVC pattern of microangiopathy (early, active, and late). Iloprost was administered to inpatients with SSc by 24-hour IV infusion for 7 consecutive days (4 μg/h).

Results. FBP was significantly lower in patients with SSc (p < 0.05) compared to controls. Heating of the LDF probe at 36°C induced a significant increase of FBP in all subjects (p < 0.001), but the slope of variation was significantly lower in patients with SSc compared to controls (p < 0.05). Patients with SSc showing the late NVC pattern of microangiopathy had significantly lower FBP than patients with the active and early NVC patterns (p < 0.05). A negative correlation was observed between FBP and NVC rating of the microvascular damage (p < 0.05). After iloprost treatment, a significant increase of FBP was observed in patients with SSc (p < 0.05).

Conclusion. Patients with SSc show a decreased FBP partially reversible by local skin heating. The FBP correlated negatively with the extent of nailfold microvascular damage, and IV iloprost treatment increased the FBP.

  • CAPILLAROSCOPY
  • SYSTEMIC SCLEROSIS
  • PERIPHERAL BLOOD FLOW
  • LASER DOPPLER FLOWMETRY
  • ILOPROST
  • MICROANGIOPATHY

Systemic sclerosis (SSc) is characterized by early and persistent microvascular impairment leading to functional [Raynaud’s phenomenon (RP)] and organic manifestations (i.e., digital ulcers). Progressive deficiency in vasodilatory capacity of the vessels is proposed as a mechanism of the persistent vascular spasm; however, the mechanism of endothelial injury is still unclear1. Digital ulcers are considered to be related to tissue ischemia following several processes, including vasospasm, intimal fibroproliferation, and thrombosis of digital arteries2.

The assessment of vascular involvement is still a matter of study, and several noninvasive techniques have been proposed. Peripheral microvascular impairment in SSc may be easily detected by nailfold videocapillaroscopy (NVC), and the morphological capillary abnormalities are classified into different patterns of microangiopathy and scored3,4. NVC may partially observe the column of red blood cells moving inside the capillary, but the technique does not allow measurement of the blood flow. Laser Doppler flowmetry (LDF) is the best technique to assess and to measure the blood perfusion at peripheral sites5,6. Blood flow has been found to be reduced in patients with SSc, compared with healthy subjects and patients with primary RP6,7.

Recently, abnormal microvascular regulatory responses to hyperemia, neurovascular reflex, and iontophoresis were demonstrated in patients with SSc with a higher Medsger vascular score, suggesting that the degree of endothelial dysfunction might be related to the degree of peripheral microvascular involvement8,9.

Our aim was to assess possible correlations between the altered blood perfusion at fingertips analyzed by LDF and the morphological microvascular abnormalities detected by NVC in patients with SSc. In addition, the effects of intravenous (IV) iloprost treatment (stable analog of prostacyclin PGI2) on fingertip blood perfusion (FBP) were investigated in patients with SSc according to their SSc pattern.

MATERIALS AND METHODS

Patients

Thirty-four consecutive women with SSc (mean age ± SD 64 ± 12 years, mean RP duration 14 ± 12 years, mean SSc duration 7 ± 7 years; Table 1) and 16 healthy subjects (mean age 61 ± 20 years) were enrolled into the study. The controls were recruited from the Rheumatologic Outpatient Clinic and had been referred for localized soft-tissue diseases (mainly soft-tissue painful conditions). The patients met the American College of Rheumatology criteria for SSc, or the criteria for the classification of early SSc10,11. Patients were recruited from the Rheumatologic Service for the Diagnosis and Management of Vascular and Connective Tissue Diseases at the University of Genoa. Informed consent was obtained from all patients.

View this table:
  • View inline
  • View popup
Table 1.

Main clinical and laboratory measures of the study patients with systemic sclerosis.

A complete medical history and comprehensive laboratory examinations were obtained from all patients, and a full medical examination was performed. All patients complained of secondary RP. The duration of both RP and SSc was evaluated by clinical interview and from clinical file data; the duration of SSc was calculated from the time of onset of clinical signs or symptoms clearly related to SSc (other than RP, i.e., skin fibrosis, dysphagia, etc.), or from the time of positive instrumental and/or laboratory investigations confirming the diagnosis (i.e., NVC, esophageal and/or pulmonary evaluation, detection of disease-specific serum autoantibodies). Esophageal evaluation was performed by manometry, pulmonary function by lung volume tests, diffusion capacity for carbon monoxide, and computed tomography; cardiac performance was investigated by Doppler echocardiography, renal function by laboratory tests and arterial Doppler echography.

All patients with SSc and healthy subjects were investigated by both NVC and LDF, in order to detect the morphological and functional microvascular status. LDF was performed in inpatients with SSc at basal time, after 24 hours, and after 1 week of continuous IV infusion of iloprost, in order to explore the reactivity of the microvascular circulation. NVC was performed at basal time and after 7 days of continuous IV iloprost infusion.

Any vasodilator drug or pharmacological treatment possibly interfering with vascular function was stopped 1 month before the clinical and instrumental examinations; this did not affect patient selection or recruitment. None of the patients was taking immunosuppressive agents for 3 months before the study. Patients had no concomitant serious systemic diseases other than SSc.

NVC was performed in each inpatient using a videocapillaroscopy optical probe equipped with a 200× contact lens and connected to image analysis software (Videocap, DS MediGroup, Milan, Italy). The same operator performed the NVC examination during the followup. Each subject was inside the building for a minimum of 15 minutes before the nailfold was examined, and the room temperature was 22–23°C. The nailfolds of the second, third, fourth, and fifth digit were examined in each patient, after a drop of immersion oil was placed on the nailfold bed to improve the image resolution.

The first line of capillaries at the nailfold was evaluated, and the following capillaroscopic measurements were considered, according to previous observations: presence of enlarged and giant capillaries, hemorrhages, loss of capillaries, disorganization of the microvascular array, and capillary ramifications12,13. The measurements were defined as (1) enlarged capillary: an increase in capillary diameter (homogeneous or irregular) > 20 μm; (2) giant capillary: homogeneously enlarged loops with a diameter > 50 μm; (3) microhemorrhage: dark mass due to hemosiderin deposit; (4) loss of capillaries: reduction of the capillary number below normal range (the normal range was adopted from the literature: 9 capillaries per linear mm, counted at the first line of the nailfold, was chosen as normal lower limit); (5) disorganization of the microvascular array: irregular capillary distribution and orientation, along with shape heterogeneity of the loops; and (6) capillary ramifications: branching, bushy, or coiled capillaries, often originating from a single normal-size capillary13–15.

A semiquantitative rating scale to score each capillary abnormality was adopted, according to previous studies (score 0–3 for every measurement: 0, no changes; 1, < 33% capillary alterations/reduction; 2, 33%–66% capillary alterations/reduction; 3, > 66% capillary alterations/reduction, per linear mm)3,4. The microangiopathy evolution score was also calculated (composite score 0–9, obtained from the sum of the scores for these measurements: loss of capillaries, disorganization of the microvascular array, and capillary ramifications)4.

Based on the NVC abnormalities, patients with SSc were distributed into the appropriate NVC pattern, as described3,12. The patterns were (1) early NVC pattern (9 patients): few (< 33%) giant capillaries, few capillary hemorrhages, relatively well preserved capillary distribution, no evident loss of capillaries; (2) active NVC pattern (11 patients): frequent (> 66%) giant capillaries, frequent capillary hemorrhages, moderate (< 33%) loss of capillaries, mild (< 33%) disorganization of the capillary architecture, absent or mild ramified capillaries; and (3) late NVC pattern (14 patients): irregular enlargement of the capillaries, few or absent giant capillaries and hemorrhages, severe (> 66%) loss of capillaries with avascular areas, disorganization of the normal capillary array, and ramified/bushy capillaries.

Laser Doppler flowmetry

LDF was performed the same day, following the NVC examination, by Periflux System 5000 equipped with a thermostatic probe (Perimed, Milan, Italy), and each subject was inside the building at least 45 minutes before the assessment, at a room temperature of 22–23°C. The subjects waited until the stated examination time seated in a waiting room. LDF was carried out analyzing the blood perfusion at second, third, fourth, and fifth fingertip bilaterally (central area), both at basal finger temperature and after heating the probe to 36°C. At basal temperature, FBP measurement was started 30–60 s after probe positioning on the central area of each fingertip, waiting for the minimal variation of the perfusion wave, and the recording was continued for 1 min in each finger; during the recording time the patient was relaxed and no noise was allowed. Subsequently the probe was heated to 36°C and a new assessment started. In the thermostatic probe the optical fibers are integrated in the heated area and thus the whole tissue area under the probe may be heated during blood perfusion measurement, to assess capillary dilation capacity. Using the thermostatic probe, perfusion assessment was started 1 min after the positioning of the probe on the fingertip: over this time, no further variation of blood perfusion due to heating was observed in our previous experiments, and the perfusion wave maintained a sinus form. The recording was continued for 1 min in every finger. In each patient, mean blood perfusion from the 8 digits was calculated, as well as the mean integration of the blood perfusion (area under the perfusion-time curve), by recording the Doppler signal. In particular, the mean value of blood perfusion was calculated by adding together the average perfusion values from the 8 fingers, and dividing the final value for 8 fingers. Results are expressed as perfusion units (PU)16, and reported as median and interquartile range (IQR).

The reproducibility of LDF assessment was 90%. Different operators blindly performed LDF and NVC examinations.

Iloprost treatment

Iloprost was administered to inpatients with SSc by 24-h IV infusion for 7 days, following current local practice (4 μg/h, in physiological solution). Inpatients with SSc had LDF before, 1 day after, and 7 days after iloprost treatment. NVC was also performed at time 0 and day 7.

Autoantibody detection

Antinuclear antibodies (ANA), antitopoisomerase I (anti-Scl-70) antibodies, and anticentromere antibodies (ACA) were determined in all patients. ANA were detected by indirect immunofluorescence using HEp-2 cells as substrate (Euroimmun, Luebeck, Germany). Anti-Scl-70 antibodies and ACA were evaluated using ELISA (Euroimmun).

Statistical analysis

The statistical analysis was carried out by nonparametric tests. The Wilcoxon test was performed to compare paired groups and Mann-Whitney U test to compare unpaired groups of variables. Possible correlations between variables were assessed by Spearman rank correlation test. A p value < 0.05 was considered statistically significant.

RESULTS

FBP was significantly lower in patients with SSc at basal temperature (p = 0.05) and at 36°C [p = 0.01; median 29 (IQR 44) and 58 (IQR 74) PU, respectively], compared to healthy controls at basal temperature and at 36°C [median 123 (IQR 195) and 183 (IQR 192) PU, respectively; Figure 1]. The heating of the probe at 36°C induced a significant increase of FBP in all subjects (p < 0.001), but the magnitude of variation (difference between the means at the 2 temperatures) was significantly lower in patients with SSc compared to controls [median 22 (IQR 33) and 34 (IQR 61) PU, respectively; p = 0.05; Figure 2].

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Fingertip blood perfusion in patients with SSc and controls (CNT) at basal temperature and after heating the probe to 36°C. Results are reported as perfusion units. Data are given with the 5th, 10th, 50th (median), 90th, and 95th percentiles.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Magnitude of variation of fingertip blood perfusion from basal finger temperature to 36°C, in patients with SSc and controls (CNT). Results are reported as perfusion units. Data are given with the 5th, 10th, 50th (median), 90th, and 95th percentiles.

Patients with SSc who had the late NVC pattern of microangiopathy showed significantly lower (half as much) FBP than patients with the active and the early NVC patterns [median at basal temperature: 28 (IQR 40), 36 (IQR 53), 60 (IQR 45) PU, respectively; p = 0.05; Figure 3]. After heating the probe, the difference in FBP among the patterns became more evident: in patients with the late pattern SSc, it was half or even less, compared to the active (p = 0.05) and the early patterns [p = 0.03; median at 36°C: 49 (IQR 46), 99 (IQR 72), 159 (IQR 49) PU, respectively]. Further, a negative correlation was observed between the FBP and NVC microangiopathy evolution score (p = 0.04; Figures 4 and 5). Interestingly, a negative correlation was also observed between FBP and duration of RP (p = 0.05). Analyzing the integration of the FBP [area under the curve (AUC)], a similar statistical significance was observed.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Fingertip blood perfusion in patients with SSc with different patterns of microvascular damage (early, active, and late), assessed by nailfold videocapillaroscopy, at basal temperature and after heating the probe to 36°C. Results are reported as perfusion units. Data are given with the 5th, 10th, 50th (median), 90th, and 95th percentiles.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Correlation between fingertip blood perfusion and microangiopathy evolution score in patients with SSc, at basal temperature.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Correlation between fingertip blood perfusion and microangiopathy evolution score in patients with SSc, after heating the probe to 36°C.

Within the limit of the small study population analyzed, no statistically significant correlation was found between FBP and presence of pulmonary, esophageal, or renal involvement in patients with SSc; however, patients with a history or presence of digital ulcers showed significantly lower FBP (p = 0.05) at 36°C than those without ulcers [median 27 (IQR 47) and 72 (IQR 75) PU, respectively]. ANA were present in 90% of patients with SSc, but no statistically significant correlation was observed between FBP and presence of either ACA or Scl-70 antibodies. No statistically significant difference in FBP was observed between patients with limited cutaneous SSc and those with diffuse cutaneous SSc.

Compared with the basal values [median 29 (IQR 44) PU], a significant increase of FBP was observed in patients with SSc after both 24 hours and 7 days of continuous iloprost treatment [median at basal temperature: 36 (IQR 80) and 48 (IQR 91) PU, respectively; p = 0.05 and p = 0.03; Figure 6]. The same trend was observed comparing the FBP values obtained after heating the probe at 36°C [median at 36°C: 58 (IQR 74), 71 (IQR 88), and 82 (IQR 93) PU, respectively], but the difference was not statistically significant (p = 0.09). The same statistical significance was observed analyzing the AUC.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Fingertip blood perfusion in patients with SSc at basal time (T0) and after 24 hours (T1) and 7 days (T7) of intravenous iloprost infusion, at basal temperature and after heating the probe to 36°C. Results are reported as perfusion units. Data are given with the 5th, 10th, 50th (median), 90th, and 95th percentiles.

No statistically significant changes were observed in the nailfold capillary abnormality scores, as assessed by NVC, after 7 days of continuous iloprost treatment. No serious adverse events were observed during iloprost infusions.

DISCUSSION

Our study clearly shows a correlation between the reduction of peripheral blood flow and the severity of nailfold microangiopathy in SSc. In particular, patients with SSc in the late NVC pattern of microangiopathy (characterized by advanced reduction of capillary number, capillary disorganization, and ramifications) showed a significantly lower FBP than patients with the active or the early NVC patterns.

Further, a statistically significant negative correlation was observed between FBP and microangiopathy evolution score. As recently demonstrated, tracking the scores of 3 capillaroscopic measurements (capillary loss, disorganization of microvascular array, and capillary ramifications) should be done together to survey the progression of SSc microangiopathy, since the relative scores usually increase during the progression of microvascular damage4. In addition, evaluation of the score for specific NVC measurements is useful to quantify the modifications of the SSc microangiopathy, when the qualitative variation between the different capillaroscopic scleroderma patterns (early, active, or late) is not evident. Qualitative and semiquantitative NVC scoring systems have been validated in a recent multicenter study17; the microangiopathy evolution score needs to be validated in larger studies. In summary, our investigation demonstrates a negative correlation between peripheral blood perfusion and the microvascular damage rating in SSc.

Our study confirms that patients with SSc are characterized by lower peripheral blood perfusion than healthy subjects. However, the low resting blood flow in patients with SSc seems reversible because the vascular reactivity to local heating seems to be partially preserved. Indeed, the FBP under thermal heating (probe at 36°C) increased in patients with SSc, even if the extent of the variation was lower than in healthy controls.

Recurrent handwarming in hot water has been proposed as a treatment for secondary RP in SSc, and is supported by the evidence of an increased blood flow associated with clinical improvement18,19. Vascular response to heating seems primarily localized to the fingers, since no increase in perfusion due to heating was found in patients with SSc or in controls when evaluated in the dorsum of the hand or in the forearm20,21. The localized reactivity seems related to a selective abnormality of the endothelial, sympathetic, and myogenic-dependent finger skin vasomotion, but it is still not clear whether the impairment reflects functional and/or structural microvascular damage8,9,21,22.

Further studies need to be done to understand whether morphological nailfold capillary abnormalities are the cause or the effect of digital blood hypoperfusion in patients with SSc. Recently, plasma levels of the vasoactive endothelin (ET-1) molecule were found to be higher in the more advanced stage of SSc microangiopathy, i.e., the late NVC pattern, and this might support the involvement of ET-1 in the pathogenesis and progression of microvascular damage in SSc23.

Our study, limited by the small sample size of patients with SSc, was not able to demonstrate any statistically significant correlations between FBP and pulmonary, esophageal, or renal involvement, or correlations with the presence of specific autoantibodies. Patients with SSc with a history or presence of digital ulcers showed significantly lower FBP.

Both the rate of blood flow and the velocity of blood flow recovery after cold provocation have been found to be lower in patients with SSc, so that cold exposure can be considered a further risk factor for ischemia, and it should be prevented in patients with SSc24.

Iloprost has been shown to be particularly effective in the treatment of digital ulcers in patients with SSc25. In a study of patients with SSc that compared low-dose and high-dose iloprost therapy over 21 days, 12% of the patients did not respond to iloprost therapy, but 78% experienced a long-lasting effect with all dosages25. Our study demonstrated a significant increase of FBP after both 24 hours and 7 days of continuous IV iloprost treatment in 90% of patients with SSc, compared with their basal FBP values. A further possible role of iloprost in promoting neoangiogenesis in SSc has been shown recently26–28. Because our investigation did not consider a control group of patients not treated with iloprost and evaluated sequentially at the same timepoints (ideally there should have been a placebo-treated control group), the positive effects shown by iloprost remain to be confirmed by further controlled studies.

Further, our study did not evaluate the clinical symptom changes to iloprost treatment in patients with secondary RP, but evaluated only the FBP, in order to search for correlations between functional and morphological instrumental detection of SSc microangiopathy.

A possible limit of our study is that it was designed to globally assess the peripheral vasculopathy at fingertips in single patients with SSc by evaluating the average perfusion/microangiopathy over 8 fingers. In fact, the microvascular impairment is not homogeneous in patients with SSc: mild capillary alterations in some digits usually coexist with severe alterations in others, as observed by NVC, and some patients may show single fingers affected by vasospasm more than others. However, even the evaluation of a single finger over the long term might add other important information, and further studies are needed to confirm these data over a larger number of patients.

Our study demonstrated that patients with SSc showed a reduced FBP that was partially reversible by local skin heating. Peripheral blood perfusion correlated negatively with the extent of the nailfold microvascular damage, being lower in patients with SSc with the late NVC pattern of microangiopathy. IV iloprost treatment increased peripheral blood perfusion, confirming its usefulness in treatment of SSc29.

The predictive power of these evaluations (NVC and FBP) is of prognostic importance for SSc, and they are also useful for early diagnosis of the disease.

Footnotes

  • Accepted for publication January 27, 2010.

REFERENCES

  1. 1.↵
    1. Kahaleh MB
    . Raynaud phenomenon and the vascular disease in scleroderma. Curr Opin Rheumatol 2004;16:718–22.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Chung L,
    2. Fiorentino D
    . Digital ulcers in patients with systemic sclerosis. Autoimmun Rev 2006;5:125–8.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Cutolo M,
    2. Pizzorni C,
    3. Tuccio M,
    4. Burroni A,
    5. Craviotto C,
    6. Basso M,
    7. et al.
    Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 2004;43:719–26.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Sulli A,
    2. Secchi ME,
    3. Pizzorni C,
    4. Cutolo M
    . Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008;67:885–7.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Engelhart M,
    2. Kristensen JK
    . Raynaud’s phenomenon: blood supply to fingers during indirect cooling, evaluated by laser Doppler flowmetry. Clin Physiol 1986;6:481–8.
    OpenUrlPubMed
  6. 6.↵
    1. Wigley FM,
    2. Wise RA,
    3. Mikdashi J,
    4. Schaefer S,
    5. Spence RJ
    . The post-occlusive hyperemic response in patients with systemic sclerosis. Arthritis Rheum 1990;33:1620–5.
    OpenUrlPubMed
  7. 7.↵
    1. Picart C,
    2. Carpentier PH,
    3. Brasseur S,
    4. Galliard H,
    5. Piau JM
    . Systemic sclerosis: blood rheometry and laser Doppler imaging of digital cutaneous microcirculation during local cold exposure. Clin Hemorheol Microcirc 1998;18:47–58.
    OpenUrlPubMed
  8. 8.↵
    1. Gunawardena H,
    2. Harris ND,
    3. Carmichael C,
    4. McHugh NJ
    . Maximum blood flow and microvascular regulatory responses in systemic sclerosis. Rheumatology 2007;46:1079–82.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Roustit M,
    2. Simmons GH,
    3. Carpentier P,
    4. Cracowski JL
    . Abnormal digital neurovascular response to local heating in systemic sclerosis. Rheumatology 2008;47:860–4.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Masi AT,
    2. Medsger TA,
    3. Rodnam GP,
    4. Fries JP,
    5. Altman RD,
    6. Brown BW,
    7. et al.
    Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581–90.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. LeRoy EC,
    2. Medsger TA Jr
    . Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573–6.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Cutolo M,
    2. Sulli A,
    3. Pizzorni C,
    4. Accardo S
    . Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155–60.
    OpenUrlPubMed
  13. 13.↵
    1. Grassi W,
    2. Medico PD,
    3. Izzo F,
    4. Cervini C
    . Microvascular involvement in systemic sclerosis: capillaroscopic findings. Semin Arthritis Rheum 2001;30:397–402.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Cutolo M,
    2. Grassi W,
    3. Matucci Cerinic M
    . Raynaud’s phenomenon and the role of capillaroscopy. Arthritis Rheum 2003;48:3023–30.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Schiavon F,
    2. Maffei P,
    3. Martini C,
    4. De Carlo E,
    5. Fais C,
    6. Todesco S,
    7. et al.
    Morphologic study of microcirculation in acromegaly by capillaroscopy. J Clin Endocrinol Metab 1999;84:3151–5.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Ahn H,
    2. Johansson K,
    3. Lundgren O,
    4. Nilsson GE
    . In vivo evaluation of signal processors for laser Doppler tissue flowmeters. Med Biol Eng Comput 1987;25:207–11.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Smith V,
    2. Pizzorni C,
    3. Keyser P,
    4. Decuman S,
    5. Van Praet JT,
    6. Deschepper E,
    7. et al.
    Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a bi-centre study. Ann Rheum Dis 2010; in press.
  18. 18.↵
    1. Goodfield MJ,
    2. Rowell NR
    . Hand warming as a treatment for Raynaud’s phenomenon in systemic sclerosis. Br J Dermatol 1988;119:643–6.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Goodfield MJ,
    2. Hume A,
    3. Rowell NR
    . The effect of simple warming procedures on finger blood flow in systemic sclerosis. Br J Dermatol 1988;118:661–8.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Murray AK,
    2. Moore TL,
    3. King TA,
    4. Herrick AL
    . Abnormal microvascular response is localized to the digits in patients with systemic sclerosis. Arthritis Rheum 2006;54:1952–60.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Salvat-Melis M,
    2. Carpentier PH,
    3. Minson CT,
    4. Boignard A,
    5. McCord GR,
    6. Paris A,
    7. et al.
    Digital thermal hyperaemia impairment does not relate to skin fibrosis or macrovascular disease in systemic sclerosis. Rheumatology 2006;45:1490–6.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Rossi M,
    2. Bazzichi L,
    3. Di Maria C,
    4. Franzoni F,
    5. Raimo K,
    6. Della Rossa A,
    7. et al.
    Blunted increase of digital skin vasomotion following acetylcholine and sodium nitroprusside iontophoresis in systemic sclerosis patients. Rheumatology 2008;47:1012–7.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Sulli A,
    2. Soldano S,
    3. Pizzorni C,
    4. Montagna P,
    5. Secchi ME,
    6. Villaggio B,
    7. et al.
    Raynaud’s phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis. J Rheumatol 2009;36:1235–9.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Kido M,
    2. Takeuchi S,
    3. Hayashida S,
    4. Urabe K,
    5. Sawada R,
    6. Furue M
    . Assessment of abnormal blood flow and efficacy of treatment in patients with systemic sclerosis using a newly developed microwireless laser Doppler flowmeter and arm-raising test. Br J Dermatol 2007;157:690–7.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Kawald A,
    2. Burmester GR,
    3. Huscher D,
    4. Sunderkötter C,
    5. Riemekasten G
    . Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud’s phenomenon and systemic sclerosis: a randomized, open, single-center study. J Rheumatol 2008;35:1830–7.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Filaci G,
    2. Cutolo M,
    3. Scudeletti M,
    4. Castagneto C,
    5. Derchi L,
    6. Gianrossi R,
    7. et al.
    Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. Rheumatology 1999;38:992–6.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Faggioli P,
    2. Giani L,
    3. Mazzone A
    . Possible role of iloprost (stable analog of PGI2) in promoting neoangiogenesis in systemic sclerosis. Clin Exp Rheumatol 2006;24:220–1.
    OpenUrlPubMed
  28. 28.↵
    1. Pola R,
    2. Gaetani E,
    3. Flex A,
    4. Aprahamian TR,
    5. Bosch-Marcé M,
    6. Losordo DW,
    7. et al.
    Comparative analysis of the in vivo angiogenic properties of stable prostacyclin analogs: a possible role for peroxisome and proliferator-activated receptors. J Mol Cell Cardiol 2004;36:331–2.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Matucci-Cerinic M,
    2. Allanore Y,
    3. Czirják L,
    4. Tyndall A,
    5. Müller-Ladner U,
    6. Denton C,
    7. et al.
    The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis 2009;68:1377–80.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 37, Issue 6
1 Jun 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Peripheral Blood Perfusion Correlates with Microvascular Abnormalities in Systemic Sclerosis: A Laser-Doppler and Nailfold Videocapillaroscopy Study
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Peripheral Blood Perfusion Correlates with Microvascular Abnormalities in Systemic Sclerosis: A Laser-Doppler and Nailfold Videocapillaroscopy Study
MAURIZIO CUTOLO, CARMELA FERRONE, CARMEN PIZZORNI, STEFANO SOLDANO, BRUNO SERIOLO, ALBERTO SULLI
The Journal of Rheumatology Jun 2010, 37 (6) 1174-1180; DOI: 10.3899/jrheum.091356

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Peripheral Blood Perfusion Correlates with Microvascular Abnormalities in Systemic Sclerosis: A Laser-Doppler and Nailfold Videocapillaroscopy Study
MAURIZIO CUTOLO, CARMELA FERRONE, CARMEN PIZZORNI, STEFANO SOLDANO, BRUNO SERIOLO, ALBERTO SULLI
The Journal of Rheumatology Jun 2010, 37 (6) 1174-1180; DOI: 10.3899/jrheum.091356
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Canadian Rheumatology Association Annual Scientific Meeting TELUS Convention Centre Calgary, Alberta, Canada February 26–March 1, 2025
  • Achievement and Usefulness of Intermediate Treatment Targets for Still Disease Proposed by the European Alliance of Associations for Rheumatology and the Paediatric Rheumatology European Society
  • School Absence Among Children With Juvenile Idiopathic Arthritis: A National Matched Comparison Study
Show more Articles

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire